Stockreport

Emmaus Life Sciences Reinforces Positive Outcomes of Endari ® Clinical Trials, Including Efficacy Findings That Led to FDA Approval

EMMAUS LIFE SCIENCES INC  (EMMA) 
PDF TORRANCE, Calif., Sept. 24, 2019 /PRNewswire/ -- Emmaus Life Sciences, Inc. (OTC: EMMA), a leader in sickle cell disease (SCD) treatment, today released the following su [Read more]